Clinical outcomes of everolimus for patients with advanced neuroendocrine tumors arising from the rectum: A singleinstitutional retrospective study

被引：0
|
作者：
Kim, Yuntae [1 ]
Hirano, Hidekazu [1 ]
Yamamoto, Shun [1 ]
Okita, Natsuko [1 ]
Shoji, Hirokazu [1 ]
Honma, Yoshitaka [1 ]
Iwasa, Satoru [1 ]
Takashima, Atsuo [1 ]
Kato, Ken [1 ]
机构：
[1] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.321
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO69-4
引用
收藏
页码：S1438 / S1438
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of everolimus (EVE) for patients with advanced rectal neuroendocrine tumors (ARNETs) - A single-institutional retrospective study
    Kim, Y.
    Hirano, H.
    Yamamoto, S.
    Okita, N.
    Shoji, H.
    Honma, Y.
    Iwasa, S.
    Takashima, A.
    Kato, K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 227 - 227
  • [2] Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea
    Kyong Joo Lee
    Jae Hee Cho
    Sang Hyub Lee
    Si Young Song
    Kwang Hyuk Lee
    Seok Jeong
    Ji Kon Ryu
    Sang Myung Woo
    Seungmin Bang
    Jong Kyun Lee
    Tae Hoon Lee
    Woo Hyun Paik
    Yong Tae Kim
    Woo Jin Lee
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 799 - 805
  • [3] Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea
    Lee, Kyong Joo
    Cho, Jae Hee
    Lee, Sang Hyub
    Song, Si Young
    Lee, Kwang Hyuk
    Jeong, Seok
    Ryu, Ji Kon
    Woo, Sang Myung
    Bang, Seungmin
    Lee, Jong Kyun
    Lee, Tae Hoon
    Paik, Woo Hyun
    Kim, Yong Tae
    Lee, Woo Jin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (04) : 799 - 805
  • [4] Clinical outcomes of everolimus in patients with advanced pancreatic neuroendocrine tumor: A multicenter study in Korea
    Joo, Lee Kyong
    Hee, Cho Jae
    Man, Kim Hee
    Hyub, Lee Sang
    Young, Song Si
    Hyuk, Lee Kwang
    Seok, Jeong
    Jikon, Ryu
    Myung, Woo Sang
    Seungmin, Bang
    Kyun, Lee Jong
    Yong-Tae, Kim
    Jin, Lee Woo
    ANNALS OF ONCOLOGY, 2017, 28
  • [5] Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
    Yao, James C.
    Phan, Alexandria T.
    Jehl, Valentine
    Shah, Gaurav
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2013, 73 (05) : 1449 - 1453
  • [6] The Efficacy of a Lower Dose of Everolimus in Patients with Advanced Neuroendocrine Tumors
    Taboada, Rodrigo G.
    Brito, Angelo B.
    Silva, Ana Luiza
    Weschenfelder, Rui F.
    Riechelmann, Rachel P.
    CANCERS, 2024, 16 (22)
  • [7] The efficacy of lower doses of everolimus in patients with advanced neuroendocrine tumors
    Riechelmann, R.
    Carvalho De Brito, A. B.
    Weschenfelder, R.
    da Silva, A. L. M.
    Gomes Taboada, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S756 - S756
  • [8] Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study
    Hanae Ida
    Yoshitaka Honma
    Hidekazu Hirano
    Hirokazu Shoji
    Satoru Iwasa
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Takahiro Fukuda
    Narikazu Boku
    Investigational New Drugs, 2019, 37 : 573 - 578
  • [9] Clinical outcomes of patients with G1/G2 neuroendocrine tumors arising from foregut or hindgut treated with somatostatin analogs: a retrospective study
    Ida, Hanae
    Honma, Yoshitaka
    Hirano, Hidekazu
    Shoji, Hirokazu
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Fukuda, Takahiro
    Boku, Narikazu
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (03) : 573 - 578
  • [10] Real-World Study on Everolimus in Advanced, Progressive Neuroendocrine Tumors
    Panzuto, F.
    Rinzivillo, M.
    Fazio, N.
    De Braud, F.
    Luppi, G.
    Degli Uberti, E.
    De Marinis, L.
    Tomassetti, P.
    Falconi, M.
    Delle Fave, G.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 277 - 277
12345